Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in hidradenitis suppurativa
NCT00329823Phase 2Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Sep 2005
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in hidradenitis suppurativa (HS), sponsored by National and Kapodistrian University of Athens. Started Sep 2005; status: completed.
02
Drugs
etanercept
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT00329823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329823.